09.05.2014 Views

Introduction to CV Pharmacology - Orlando Health

Introduction to CV Pharmacology - Orlando Health

Introduction to CV Pharmacology - Orlando Health

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>CV</strong> <strong>Pharmacology</strong><br />

Hydralazine<br />

Hydralazine has direct vasodila<strong>to</strong>ry effects on the vascular smooth muscle resulting in blood<br />

pressure lowering. It is one of the parenteral drugs of choice for management of pregnancyassociated<br />

hypertensive emergencies. However, other parenteral therapies (i.e., nitroprusside) are<br />

recommended for hypertensive crises in non-pregnant patients. When used parenterally,<br />

hydralazine is administered as intermittent doses. Hydralazine has been used in combination with<br />

isosorbide dinitrate as a second-line treatment of heart failure.<br />

Nesiritide (Natrecor)<br />

Nesiritide is a synthetic human B-type natriuretic peptide (BNP) with potent vasodila<strong>to</strong>r<br />

properties. Nesiritide binds <strong>to</strong> the recep<strong>to</strong>r sites of vascular smooth muscle resulting in an<br />

increase in cGMP, which is responsible for vasodilation of veins and arteries. It promotes<br />

diuresis and natruresis. It is currently indicated for the patient in acutely decompensated heart<br />

failure who is symp<strong>to</strong>matic with either minimal activity or dyspnea at rest.<br />

Precautions<br />

When B-type natriuretic peptide (BNP) lab values are ordered, the blood must be obtained prior<br />

<strong>to</strong> the administration of nesiritide (Natrecor). Since nesiritide (Natrecor) is a synthetic BNP, the<br />

lab results will be altered after this drug is administered.<br />

Due <strong>to</strong> its potent hypotensive properties, it is important <strong>to</strong> institute frequent blood pressure<br />

moni<strong>to</strong>ring. Review your institution’s policy regarding placement of the patient in an<br />

appropriate telemetry unit.<br />

© 2010 <strong>Orlando</strong> <strong>Health</strong>, Education & Development 31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!